arginine has been researched along with Craniofacial Dysarthrosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, M; Ke, R; Lei, J; Mu, X; Tianyi, C; Yang, X | 1 |
Ang, BU; Kirschner, RE; Nah, HD; Spivak, RM | 1 |
Gong, SG | 1 |
Anderson, PJ; Cox, TC; David, DJ; Netherway, DJ; Roscioli, T | 1 |
Aisa, C; Baroni, T; Bellucci, C; Bodo, M; Carinci, F; Carinci, P; Lilli, C; Lumare, E; Pezzetti, F; Scapoli, L; Stabellini, G | 1 |
Boles, RG; Dhamcharee, V | 1 |
Nakakita, N; Sakai, N; Sakata, Y; Shida, H; Susami, T; Takato, T; Tokunaga, K; Uchinuma, E; Yamazaki, Y | 1 |
7 other study(ies) available for arginine and Craniofacial Dysarthrosis
Article | Year |
---|---|
The C342R mutation in FGFR2 causes Crouzon syndrome with elbow deformity.
Topics: Amino Acid Substitution; Arginine; Asian People; Child; Child, Preschool; China; Craniofacial Dysostosis; Cysteine; Elbow Joint; Female; Genetic Carrier Screening; Humans; Joint Dislocations; Male; Mutation; Olecranon Process; Phenotype; Receptor, Fibroblast Growth Factor, Type 2 | 2015 |
Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Topics: Acrocephalosyndactylia; Adenoviridae; Alkaline Phosphatase; Animals; Arginine; Biomarkers; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coculture Techniques; Coloring Agents; Core Binding Factor Alpha 1 Subunit; Craniofacial Dysostosis; Craniosynostoses; Cysteine; Dura Mater; Genetic Vectors; Mice; Osteoblasts; Osteogenesis; Osteopontin; Phenylalanine; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Syndrome; Tetrazolium Salts; Thiazoles | 2010 |
The Fgfr2 W290R mouse model of Crouzon syndrome.
Topics: Animals; Arginine; Bone and Bones; Cartilage; Cranial Sutures; Craniofacial Dysostosis; Disease Models, Animal; Humans; Mice; Mutation; Phenotype; Receptor, Fibroblast Growth Factor, Type 2; Tryptophan | 2012 |
Do Craniosynostosis syndrome phenotypes with both FGFR2 and TWIST mutations have a worse clinical outcome?
Topics: Acrocephalosyndactylia; Adenine; Adolescent; Arginine; Child, Preschool; Craniofacial Dysostosis; Craniosynostoses; Cysteine; Cytosine; DNA Transposable Elements; Female; Follow-Up Studies; Guanine; Humans; Male; Mutation; Receptor, Fibroblast Growth Factor, Type 2; Sequence Deletion; Serine; Syndrome; Thymine; Treatment Outcome; Tryptophan; Twist-Related Protein 1 | 2006 |
FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
Topics: Acrocephalosyndactylia; Adolescent; Arginine; Cell Count; Collagen Type I; Craniofacial Dysostosis; DNA Mutational Analysis; Extracellular Matrix; Fibroblast Growth Factor 2; Fibroblasts; Fibronectins; Glycoside Hydrolases; Humans; Matrix Metalloproteinase 1; Mutation; Peptide Hydrolases; Periosteum; Phenotype; Proline; Proteoglycans; Receptor, Fibroblast Growth Factor, Type 2; RNA, Messenger | 2007 |
FGFR mutations and plagiocephaly.
Topics: Acrocephalosyndactylia; Arginine; Craniofacial Dysostosis; Craniosynostoses; Electrophoresis; Exons; Genetic Predisposition to Disease; Genetic Variation; Humans; Infant; Mutation; Plagiocephaly, Nonsynostotic; Proline; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor | 2008 |
Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.
Topics: Acrocephalosyndactylia; Arginine; Cleft Palate; Codon; Craniofacial Dysostosis; Craniosynostoses; Exons; Female; Heterozygote; Humans; Japan; Male; Mutation; Polymerase Chain Reaction; Proline; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Sequence Analysis, DNA; Serine; Syndactyly; Tryptophan | 2001 |